These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 8549402)

  • 1. Antimicrobial treatment of cholera.
    Salam MA; Khan WA; Begum M; Bardhan PK; Islam MR; Mahalanabis D
    Drugs; 1995; 49 Suppl 2():466-9. PubMed ID: 8549402
    [No Abstract]   [Full Text] [Related]  

  • 2. Antimicrobial treatment of adults with cholera due to Vibrio cholerae 0139 (synonym Bengal).
    Khan WA; Dhar U; Begum M; Salam MA; Bardhan PK; Mahalanabis D
    Drugs; 1995; 49 Suppl 2():460-2. PubMed ID: 8549400
    [No Abstract]   [Full Text] [Related]  

  • 3. Large epidemic of cholera-like disease in Bangladesh caused by Vibrio cholerae O139 synonym Bengal. Cholera Working Group, International Centre for Diarrhoeal Diseases Research, Bangladesh.
    Lancet; 1993 Aug; 342(8868):387-90. PubMed ID: 8101899
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antimicrobial resistance surveillance of Vibrio cholerae in Thailand from 2000 to 2004.
    Supawat K; Huttayananont S; Sawanpanyalert P; Aswapokee N; Mootsikapun P
    J Med Assoc Thai; 2009 Aug; 92 Suppl 4():S82-6. PubMed ID: 21294503
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ciprofloxacin for treating cholera.
    Maggi P; Carbonara S; Santantonio T; Pastore G; Angarano G
    Lancet; 1996 Nov; 348(9039):1446-7. PubMed ID: 8937293
    [No Abstract]   [Full Text] [Related]  

  • 6. Tetracycline in the treatment of cholera caused by Vibrio cholerae O1 resistant to the drug in vitro.
    Khan AM; von Gierke U; Hossain MS; Fuchs GJ
    J Health Popul Nutr; 2003 Mar; 21(1):76-8. PubMed ID: 12751678
    [No Abstract]   [Full Text] [Related]  

  • 7. Occurrence of transferable multi-drug resistance in Vibrio cholerae-O1 in an endemic area.
    Sundaram SP; Murthy KV
    Indian J Med Res; 1984 Jun; 79():722-7. PubMed ID: 6519698
    [No Abstract]   [Full Text] [Related]  

  • 8. Identification of Widespread Antibiotic Exposure in Patients With Cholera Correlates With Clinically Relevant Microbiota Changes.
    Alexandrova L; Haque F; Rodriguez P; Marrazzo AC; Grembi JA; Ramachandran V; Hryckowian AJ; Adams CM; Siddique MSA; Khan AI; Qadri F; Andrews JR; Rahman M; Spormann AM; Schoolnik GK; Chien A; Nelson EJ
    J Infect Dis; 2019 Oct; 220(10):1655-1666. PubMed ID: 31192364
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multidrug resistance in Vibrio cholerae.
    Anand VK; Arora S; Patwari AK; Agarwal GD; Dewan N
    Indian Pediatr; 1996 Sep; 33(9):774-7. PubMed ID: 9057408
    [No Abstract]   [Full Text] [Related]  

  • 10. Antimicrobial suceptibility of V. cholerae in north west, Ethiopia.
    Abera B; Bezabih B; Dessie A
    Ethiop Med J; 2010 Jan; 48(1):23-8. PubMed ID: 20607994
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Bacteriologic data on Vibrio cholerae strains isolated in Senegal].
    Castets M; Sarrat H; Mora M
    Bull Soc Med Afr Noire Lang Fr; 1972; 17(4):631-5. PubMed ID: 4666268
    [No Abstract]   [Full Text] [Related]  

  • 12. Diversity of Vibrio cholerae strains isolated in Delhi, India, during 1992-2000.
    Das S; Gupta S
    J Health Popul Nutr; 2005 Mar; 23(1):44-51. PubMed ID: 15884751
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Resistance to antibiotics of Vibrio cholerae and its possible prognostic significance].
    Ved'mina EA; Givental' NI; Sobolev VR; Ogneva NS; Voronin IuS
    Antibiotiki; 1984 Apr; 29(4):260-3. PubMed ID: 6742803
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tetracycline resistant cholera in Kelantan.
    Ranjit K; Nurahan M
    Med J Malaysia; 2000 Mar; 55(1):143-5. PubMed ID: 11072502
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vibrio cholerae 01 strain resistant to vibriostatic compound 0/129 isolated from cholera cases in Kilifi, Kenya.
    Khamala JK; Mwarumba S; Lewa P; Lowe B
    East Afr Med J; 2002 Oct; 79(10):560. PubMed ID: 12635766
    [No Abstract]   [Full Text] [Related]  

  • 16. Comparison of single-dose azithromycin and 12-dose, 3-day erythromycin for childhood cholera: a randomised, double-blind trial.
    Khan WA; Saha D; Rahman A; Salam MA; Bogaerts J; Bennish ML
    Lancet; 2002 Nov; 360(9347):1722-7. PubMed ID: 12480424
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Isolation of Vibrio cholerae from neonates admitted to an urban diarrhoeal diseases hospital in Bangladesh.
    Khan AM; Faruque AS; Hossain MS
    Ann Trop Paediatr; 2005 Sep; 25(3):179-82. PubMed ID: 16156982
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Computer based screening for novel inhibitors against Vibrio cholerae using NCI diversity set-II: an alternative approach by targeting transcriptional activator ToxT.
    Mondal SI; Khadka B; Akter A; Roy PK; Sultana R
    Interdiscip Sci; 2014 Jun; 6(2):108-17. PubMed ID: 25172449
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Bacteriological aspects of cholera in Chad (1991 and 1994 epidemics)].
    Massenet D; Djerane L; Gamougane K; Fournier JM
    Bull Soc Pathol Exot; 1995 Mar; 88(4):203-5. PubMed ID: 8640086
    [No Abstract]   [Full Text] [Related]  

  • 20. Emergence of tetracycline-resistant Vibrio cholerae O1 serotype Inaba, in Kolkata, India.
    Roychowdhury A; Pan A; Dutta D; Mukhopadhyay AK; Ramamurthy T; Nandy RK; Bhattacharya SK; Bhattacharya MK
    Jpn J Infect Dis; 2008 Mar; 61(2):128-9. PubMed ID: 18362401
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.